Human microbiomes in neurodegenerative diseases: an overview of their potential involvement
Alejandro Borrego-Ruiz , Juan J. Borrego
Exploration of Neuroprotective Therapy ›› 2026, Vol. 6 ›› Issue (1) : 1004153
By individual examination, the present review provides an overview of the potential involvement of various human microbiomes, including the gut, oral, skin, and nasal, in the pathophysiology of neurodegenerative diseases. Research has demonstrated that gut microbiome dysbiosis is linked to the pathogenesis of neurodegenerative conditions, including Alzheimer’s, Parkinson’s, and Huntington’s diseases, through mechanisms involving microbial metabolites, neuroinflammation, amyloid aggregation, and altered neurotransmission. Emerging evidence suggests that the oral, skin, and nasal microbiomes may also influence neurodegenerative diseases through mechanisms such as microbial translocation, immune modulation, metabolite production, and interactions with the gut-brain axis. Although the potential of microbiome-based interventions for neurodegenerative diseases has been highlighted, several gaps remain, such as variability between human and animal models, a lack of standardized multi-omics approaches, and a limited understanding of individual microbial roles. Future studies should focus on clarifying the mechanisms by which dysbiosis in human host microbiomes impacts the pathophysiology of neurodegenerative diseases, identifying reliable biomarkers, and developing safe and effective microbiome-based therapies.
neurodegenerative diseases / Alzheimer’s disease / Parkinson’s disease / Huntington’s disease / gut microbiome / oral microbiome / skin microbiome / nasal microbiome
| [1] |
|
| [2] |
|
| [3] |
American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5-TR™. 5th ed. Washington: American Psychiatric Publishing Inc.; 2022. |
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
Hashimoto K, |
| [20] |
McEwen BS. Hormones and behavior and the integration of brain-body science. Horm Behav. 2020; 119: 104619. |
| [21] |
Integrative HMP (iHMP) Research Network Consortium. The Integrative Human Microbiome Project. Nature. 2019; 569: 641-8. |
| [22] |
|
| [23] |
Berg G, Rybakova D, Fischer D, Cernava T, |
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
Santoro A, Zhao J, Wu L, Carru C, Biagi E, |
| [29] |
|
| [30] |
|
| [31] |
Hashimoto K. Neuroinflammation through the vagus nerve-dependent gut-microbiota-brain axis in treatment-resistant depression. Prog Brain Res. 2023; 278: 61-77. |
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
Ferreiro AL, Choi J, Ryou J, Newcomer EP, Thompson R, Bollinger RM, |
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
|
| [53] |
Bostanciklioğlu M. The role of gut microbiota in pathogenesis of Alzheimer’s disease. J Appl Microbiol. 2019; 127: 954-67. |
| [54] |
|
| [55] |
|
| [56] |
|
| [57] |
|
| [58] |
|
| [59] |
|
| [60] |
|
| [61] |
|
| [62] |
|
| [63] |
|
| [64] |
|
| [65] |
|
| [66] |
|
| [67] |
|
| [68] |
|
| [69] |
|
| [70] |
|
| [71] |
|
| [72] |
|
| [73] |
|
| [74] |
|
| [75] |
|
| [76] |
|
| [77] |
|
| [78] |
|
| [79] |
|
| [80] |
|
| [81] |
|
| [82] |
|
| [83] |
|
| [84] |
|
| [85] |
|
| [86] |
|
| [87] |
|
| [88] |
|
| [89] |
|
| [90] |
|
| [91] |
|
| [92] |
|
| [93] |
|
| [94] |
|
| [95] |
|
| [96] |
|
| [97] |
Narengaowa, |
| [98] |
|
| [99] |
|
| [100] |
|
| [101] |
|
| [102] |
|
| [103] |
|
| [104] |
|
| [105] |
|
| [106] |
|
| [107] |
|
| [108] |
|
| [109] |
|
| [110] |
|
| [111] |
|
| [112] |
|
| [113] |
|
| [114] |
|
| [115] |
|
| [116] |
Gan G, Chen R, Zheng P, Long K, |
| [117] |
|
| [118] |
Xiao X, Zhang X, Wang J, Liu Y, Yan H, Xing X, |
| [119] |
|
| [120] |
Hajishengallis G. Periodontitis: From microbial immune subversion to systemic inflammation. Nat Rev Immunol. 2015; 15: 30-44. |
| [121] |
|
| [122] |
|
| [123] |
|
| [124] |
|
| [125] |
|
| [126] |
|
| [127] |
Wang P, Rajput D, Wang X, Huang C, |
| [128] |
|
| [129] |
|
| [130] |
|
| [131] |
|
| [132] |
|
| [133] |
|
| [134] |
|
| [135] |
|
| [136] |
|
| [137] |
|
| [138] |
|
| [139] |
|
| [140] |
|
| [141] |
|
| [142] |
Song H, Zou J, Sun Z, Pu Y, Qi W, Sun L, |
| [143] |
Villar-Gómez N, |
| [144] |
|
| [145] |
|
| [146] |
|
| [147] |
|
| [148] |
|
| [149] |
|
| [150] |
|
| [151] |
|
| [152] |
|
/
| 〈 |
|
〉 |